CN
HOME>Company News>Effectiveness Statement of Real-Time PC Kit for Novel Coronavirus 2019-CoV Variants Detection

Effectiveness Statement of Real-Time PC Kit for Novel Coronavirus 2019-CoV Variants Detection

2021-08-03

We, Shenzhen Uni-medica Technology Co., Ltd, Address: Room202, Block 6th, LiuXian Culture Park, XiLi Town, Nanshan District, Shenzhen, Guangdong Province, 51805S, P. R. China hereby declare that Uni-medica Real-Time PC Kit for Novel Coronavirus 2019-nCoV can detect all types of mutations, which included but not limited to Alpha(B.1.1.7+Q), Beta(B.1.351, B.1.351.2, B.1.351.3), Gamma(P.I, P.I.I, P.1.2, P.1.4, P.1.6, P.I.7), Delta(B.1.617.2+AY.x), Eta(B.1.525), Lota(B.1.526), Kappa(B.1.617.1), Lambda(C.37), Zeta(P.2), Omicron(B.1.1.529),etc

Referring to the newly emerged variants of the novel coronavirus, our silicon analysis have proved the target region alignment of our Real-Time PC Kit for Novel Coronavirus 2019-nCoV (Cat#R030-02.R033-01.R033-02.R033-03.R033-04.R034-01.R034-02.R034-03,R034-04), which showed that Uni-medica kits can detect all the above variants without false-negative results off-target situations.

As usual, we will continue to track and update the latest viral information including mutations and substitutions for SARS-CoV-2 to maintain the specificity and sensitivity of our products.

Thanks for your trust and support.

Message